Welcome to Pangaea insights
Our collective intelligence provides an unrivalled breadth and depth of knowledge.
Pangaea’s ongoing relationships with key industry stakeholders facilitate continuous updates and dissemination of relevant market intelligence. Check back often for new posts!
Pangaea Express: PMPRB Notice and Comment
July 20, 2022
In the period between the coming into force of the new Patented Medicines Regulations and the final publication of a corresponding set of guidelines (“Interim Period”), the PMPRB is proposing to adopt a “status quo” approach to carrying out its regulatory mandate.
Pangaea Express: Quebec Releases Rare Disease Policy
July 15, 2022
The Quebec government has released its provincial Rare Disease Policy. This is the first jurisdiction in Canada to develop a policy for rare diseases that aims to help patients suffering from a rare disease gain better access to diagnosis, health care and treatment.
Pangaea Express: PMPRB releases a statement, April 22, 2022
April 25, 2022
The PMPRB has responded to the statement made April 14, 2022, by the Federal Minister of Health, Minister Duclos regarding the Coming-into-Force of the Regulations Amending the Patented Medicines Regulations.
Pangaea Express: Supreme Court of Canada Dismisses Appeal in SOLIRIS case
March 28, 2022
On March 24, 2022, the Supreme Court of Canada dismissed the application by the Attorney General of Canada in its appeal to the Federal Court Decision in the SOLIRIS case.
Pangaea Express: Quebec Court of Appeal Case
February 25, 2022
The Quebec Court of Appeal has confirmed that is it unconstitutional for the PMPRB to compel companies to provide information from 3rd party agreements.
Pangaea Express: Delay until July 1, 2022 for Patented Medicines Regulations
December 24, 2021
On December 23, 2021, the Minister of Health, Jean-Yves Duclos announced a delay in the coming-into-force of the Regulations Amending the Patented Medicines Regulations by six months.
Pangaea Express: PMPRB Not Moving Forward July 15 with Proposed Changes
December 20, 2021
On December 17, 2021, the PMPRB posted an update that read, “The Board has decided not to proceed with the changes that were proposed in the July 15, 2021 Notice and Comment.
Pangaea Express: What to Make of the Latest Announcements re: PMPRB?
August 5, 2021
Read about the two major announcements have been made in the last couple of weeks pertaining to the PMPRB.
Pangaea Express: Establishment of Advisory Panel to Design Pan-Canadian Formulary
July 28, 2021
CADTH has announced the establishment of a Special Advisory Panel to design a potential pan-Canadian formulary.
Pangaea Express: PMPRB Third Delay
June 28, 2021
The PMPRB has updated their website to state the coming-into-force of the amended Patented Medicines Regulations has been further delayed until January 1, 2022.